Labcorp
New blood test helps assess preeclampsia risk during first trimester
May 23, 2024

Labcorp has launched the new screening tool for use at 11 to 14 weeks' gestation to help determine the risk of developing preeclampsia before 34 weeks of pregnancy. The test was designed for all pregnant people in mind, including those with low to average preeclampsia risk and those who are pregnant for the first time. Tap for details ...
TRENDING THIS WEEK